In the final episode of CurveChats, our COO, CTO, CSO, and CEO discuss Curve’s vision for the future of chronic disease monitoring. The conversation covers how Curve ultimately looks to build the multi-organ Whole-Body Blood Test for chronic disease monitoring, building our lab with modularity and mobility in mind to scale, and the flywheel of data from our liver cirrhosis and liver inflammation monitoring tests and beyond.